Matthew Hobson
InvestorAnalyst at Catalio Capital Management, LP
Baltimore, Maryland
Writes $100K – $5M checks · typically $1.5M
About
Matthew Hobson is a Principal at Catalio Capital Management, where he focuses on therapeutics and diagnostics investments across the firm's venture and private credit strategies. He joined Catalio at its 2020 founding, having previously been a Postdoctoral Fellow at the Johns Hopkins School of Medicine, where he also earned a PhD in biophysics and biophysical chemistry. He holds a B.S. in chemistry and physics from Emory University.
Contact· self-published, not guessed
Invests in
BiotechDigital Health
Experience
- Catalio Capital ManagementPrincipalcurrent2023 — presentNew York, United States
- Catalio Capital ManagementSr. Analyst2020 — 2023New York, New York, United States
- The Johns Hopkins University School of MedicinePostdoctoral Researcher2020 — 2021Baltimore, Maryland, United States
- The Johns Hopkins University School of MedicinePHD Candidate2013 — 2020Baltimore, Maryland
- Emory University Department of ChemistryUndergraduate Researcher2010 — 2013
- National Institutes of HealthContractor2010 — 2012NIH Clinical Center, Bethesda, MD
- Walter Reed Army Institute of ResearchIntern2009
Skills & more
Financial AnalysisValuationRegulatory AnalysisClinical Trial AnalysisProtein EngineeringStructural BiologyMarket AnalysisData AnalysisMicroscopyAssay DevelopmentMarket ResearchProtein Expression
+12 more
Fluorescence MicroscopyProtein PurificationCryoEMBiophysicsComputational BiologyX-ray crystallographyVector CloningChemical SynthesisFluorescence AnisotropyProtein CrystallizationNanoparticle FunctionalizationMagnetic TweezersFrom Matthew's professional profile.
Investments
Board seats
Iambic TherapeuticsLassen TherapeuticsOctant TherapeuticsPink Dx
Per the firm's website.
Colleagues at Catalio Capital Management, LP
Adam Riess
Venture Partner at Catalio Capital Management, LP
Alan Ashworth
Venture Partner at Catalio Capital Management, LP
Christine E. 'Kricket' Seidman
Venture Partner at Catalio Capital Management, LP
Dan Littman
Venture Partner at Catalio Capital Management, LP
David Sinclair
Venture Partner at Catalio Capital Management, LP
Diamantis Xylas
Analyst at Catalio Capital Management, LP
Frances H. Arnold
Venture Partner at Catalio Capital Management, LP
Freda Lewis-Hall
Venture Partner at Catalio Capital Management, LP
Frequently asked questions
- Who is Matthew Hobson?
- Matthew Hobson is a Principal at Catalio Capital Management, where he focuses on therapeutics and diagnostics investments across the firm's venture and private credit strategies. He joined Catalio at its 2020 founding, having previously been a Postdoctoral Fellow at the Johns Hopkins School of Medicine, where he also earned a PhD in biophysics and biophysical chemistry. He holds a B.S. in chemistry and physics from Emory University.
- Where does Matthew Hobson work?
- Matthew Hobson is Analyst at Catalio Capital Management, LP.
- What does Matthew Hobson invest in?
- Matthew Hobson invests in Biotech, Digital Health.
- What check size does Matthew Hobson write?
- Matthew Hobson typically writes checks of $100K – $5M.
- What boards does Matthew Hobson sit on?
- Matthew Hobson holds tracked board seats at Iambic Therapeutics, Lassen Therapeutics, Octant Therapeutics, Pink Dx.
- Where did Matthew Hobson go to school?
- Matthew Hobson studied at The Johns Hopkins University School of Medicine (Doctor of Philosophy - PhD, Biophysics and Biophysical Chemistry); Emory University (Bachelor of Science (B.S.), Chemistry and Physics); The Johns Hopkins University (Doctor of Philosophy (PhD), Biophysics).
Same school
Also attended The Johns Hopkins University School of Medicine28
Hal PazInvestor at Khosla VenturesRochelle WalenskyExecutive Partner at Flare Capital PartnersBeth SeidenbergFounding Managing Director at Westlake Village BioPartnersS.K. LeeExecutive Coach at Roble VenturesKayarash KarimianSenior Associate at Cure VenturesSamantha GuinnAnalyst at Novartis Venture Fund
.png)
+ 22 more
Also attended Emory University124
William HockeyCo-founder of Plaid; founder & CEO of ColumnDave MunichielloInvestor at GV (Google Ventures)Ryan HaysBoard Member at CincyTechJustin RobenyAssociate at Osage University PartnersZitong SuAssociate at Marlin Equity PartnersGurbani SinghPrincipal - Investor Relations at Marlin Equity Partners
+ 118 more
Also attended The Johns Hopkins University261
Wes NicholsPartner at March Capital PartnersDemi ObayomiPrincipal at Sapphire VenturesJun JeonInvestor at Khosla VenturesNicole FraenkelInvestor at Khosla VenturesElena VibochManaging Director at General CatalystScott RubinVenture Partner at Lux Capital
+ 255 more
Shared employers
Also worked at Catalio Capital Management11
George C. PetrocheilosCo-Founder and Managing Partner at Catalio Capital Management, LPR. Jacob VogelsteinCo-Founder and Managing Partner at Catalio Capital Management, LPTom V. BrooksPartner at Catalio Capital Management, LPNicholas von GuionneauSenior Analyst at Catalio Capital Management, LPJohn Henry IuckerGeneral Partner and Head of Credit at Catalio Capital Management, LPVicky SostilioVice President at Catalio Capital Management, LP
+ 5 more
Also worked at The Johns Hopkins University School of Medicine13
Yoola AdenijiSenior Associate at LRVHealthRobert LordVenture Partner at LionBirdLuc StarmansPartner at Brightlands Venture PartnersMichelle LevinePrincipal at Solasta VenturesDoug KerrScience Advisor at Exceptional VenturesKiran YemulFellow, Healthcare & Life Sciences at Braven
+ 7 more
Also worked at National Institutes of Health60
Jun JeonInvestor at Khosla VenturesUri LopatinInvestor at Khosla VenturesMax ColbertPhysician-Entrepreneur at Medical Excellence CapitalIan ChiangPartner at Flare Capital PartnersGrant VerstandigFounder, Chairman, & CEO at Red Cell IncubationLeela SrinivasanCEO, Parity at Bull City Venture Partners
+ 54 more